<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04549142</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-56622</org_study_id>
    <secondary_id>R01ES032253</secondary_id>
    <nct_id>NCT04549142</nct_id>
  </id_info>
  <brief_title>Immune Tolerance Dysfunction in Pregnancy Due to Ambient Air Pollution Exposure</brief_title>
  <official_title>Immune Tolerance Dysfunction in Pregnancy Due to Ambient Air Pollution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Environmental Health Sciences (NIEHS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to study the effects of air pollution toxicants on pregnant&#xD;
      mothers' immune health during and after pregnancy.&#xD;
&#xD;
      Using already collected samples, this study proposes to evaluate changes in immune function&#xD;
      in response to air pollution with the use of innovative technologies, to identify the drivers&#xD;
      of immune dysfunction and potential modifiable factors, and to determine how these immune&#xD;
      findings are associated with pollution exposure and outcomes of disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in immune cell subset identity and function in pregnant vs. non pregnant women exposed to high vs. low pollution over time</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Identify the epigenetic molecular mechanisms driving immune dysfunction in pregnancy vs. no pregnancy with high vs. low PM2.5 exposure over time</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Map T cell receptor diversity to immune dysfunction in pregnancy vs non pregnancy with high vs. low PM2.5 exposure over time</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">400</enrollment>
  <condition>Air Pollution</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Pregnant women- high level pollution</arm_group_label>
    <description>Exposed to high levels of pollution (PM2.5)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregnant women- low level pollution</arm_group_label>
    <description>Exposed to low levels of pollution (PM2.5)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-pregnant women-high level pollution</arm_group_label>
    <description>Exposed to high levels of pollution (PM2.5)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-pregnant women-low level pollution</arm_group_label>
    <description>exposed to low levels of pollution (PM2.5)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>There is no intervention</intervention_name>
    <description>There is no intervention</description>
    <arm_group_label>Non-pregnant women-high level pollution</arm_group_label>
    <arm_group_label>Non-pregnant women-low level pollution</arm_group_label>
    <arm_group_label>Pregnant women- high level pollution</arm_group_label>
    <arm_group_label>Pregnant women- low level pollution</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women at 18-25 weeks gestation and non-pregnant women&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women: at 18-25 weeks gestation at time of eligibility screening and baseline&#xD;
             visit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having smoked more than 50 cigarettes during pregnancy&#xD;
&#xD;
          -  A history of autoimmune diseases, HIV or cancer&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kari Nadeau, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sean N. Parker Center for Allergy &amp; Asthma Research at Stanford University</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Kari Christine Nadeau, MD, PhD</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>immune function</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

